Dr. Kenneth I. Ataga, MD
- Medicare services, 2023
- 19
- Medicare patients, 2024
- 15
- Part D claims, 2024
- 133
- Publications
- 110
- Clinical trials
- 6
- Practice address
- 877 Jefferson Avenue, Memphis, TN 38103
- Practice phone
- Call (901) 545-7928
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Ataga's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kenneth I. Ataga is a hematologist and oncologist in Memphis, Tennessee
Dr. Ataga practices at Regional Medical Center in Memphis, Tennessee, part of Shelby County Government.
Dr. Ataga's NPI, 1306886825, was assigned on June 7, 2006. Dr. Ataga holds Tennessee license 57803.
- NPI
- 1306886825NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3375679145
- NPI enumeration date
- June 7, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (901) 545-7928
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kenneth I. Ataga practices at Regional Medical Center in Memphis, Tennessee
Dr. Ataga's primary practice is Regional Medical Center, at 877 Jefferson Avenue, Memphis, TN 38103 in Shelby County. The practice phone is (901) 545-7928.
- Regional Medical Center877 Jefferson Avenue, Memphis, TN 38103 · Shelby CountyPhone(901) 545-7928
Source: Dmand AI Affiliation Data
Dr. Kenneth I. Ataga is affiliated with 3 sites of care and 3 medical groups
Dr. Ataga's primary practice is Regional Medical Center in Memphis, Tennessee, part of Shelby County Government. Dr. Ataga is also affiliated with Select Specialty Hospital - Memphis. The medical group on file is UT Regional One Physicians. Dmand AI also links Dr. Ataga to 2 more medical groups and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Kenneth I. Ataga's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ataga practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Regional Medical Center | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Shelby County Government and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kenneth I. Ataga is one of 271 hematologists and oncologists in Tennessee
Hematology and oncology is Dr. Ataga's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Ataga's licenses on file in 2 states: Tennessee and North Carolina.
Specialties and state licenses
- Hematology and oncology, TennesseePrimary
- North Carolina license
Hematologists and oncologists near Dr. Ataga
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kenneth I. Ataga billed Medicare for 19 services in 2023
CMS data shows 19 Medicare services from Dr. Ataga across 1 procedure code in 2023, all of them office visits, for 15 Medicare patients. Medicare paid $1,210 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Ataga's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 332023: 1942%
Dr. Ataga compared with the Tennessee median for hematologists and oncologists, 2023
- Dr. Ataga
- Tennessee median
- Medicare services
- 19vs 81898% below
- Medicare patients
- 15vs 28795% below
- Part D claims
- 77vs 50885% below
Medians across 259 hematologists and oncologists in Tennessee with Dmand AI profiles that report each measure.
Dr. Ataga's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Ataga?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Ataga and other hematologists and oncologists in Tennessee.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kenneth I. Ataga treated 15 Medicare patients in 2024, average age 49
CMS counts 15 Medicare patients who saw Dr. Ataga in 2024. 73% of them have high blood pressure. Their average risk score is 5.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Ataga's median patient age at 41, with 45% women.
Chronic conditions among Dr. Ataga's Medicare patients, 2024
- High blood pressure73%
Share of Medicare patients with each condition. A patient can have several.
Dr. Ataga's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 41
Patient panel by sex, all payers
- Women45%
- Men55%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kenneth I. Ataga wrote 133 Medicare Part D claims in 2024
In 2024, Dr. Ataga wrote 133 Medicare Part D claims for 18 patients. 70% of them were for generic drugs. CMS names the drug for 77 of them, across 5 drugs with 11 or more claims each, at $320,430 in total drug cost. In 2023, CMS named 103 claims across 5 drugs.
Dr. Ataga's Part D claims by kind of drug, 2024
- Generic93 claims70%
- Brand-name40 claims30%
Dr. Ataga's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Ataga's Part D claims, 2024
- Opioids16%21 of 133 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1032024: 7725%
Drugs named by CMS: 5 in 2024, 5 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Kenneth I. Ataga scored 81 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Ataga for performance year 2024, reported as part of a group. Dr. Ataga accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Ataga's MIPS scores, performance year 2024
- 81of 100Final score
- 64.6of 100Quality
- 40of 100Improvement Activities
- 77of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kenneth I. Ataga has 110 publications on record
Dmand AI links 110 papers to Dr. Ataga, published from 2008 to 2025. 2021 was the busiest year, with 11. The most frequent topics are Anemia, Sickle Cell, Hydroxyurea and Hypertension, Pulmonary. Dr. Ataga has published most often in Br J Haematol. Dr. Ataga's most frequent co-authors are Payal Chandarana Desai, MD, Nigel S. Key, MD and Santosh Lumdas Saraf, MD.
Dr. Ataga's papers by year, 2016 to 2025
Topics Dr. Ataga writes about most
- Anemia, Sickle Cell
- Hydroxyurea
- Hypertension, Pulmonary
- Albuminuria
- Double-Blind Method
- Glomerular Filtration Rate
- Kidney Diseases
- Antisickling Agents
Dr. Ataga's most frequent co-authors
- Payal Chandarana Desai, MD15 shared papers
- Nigel S. Key, MD15 shared papers
- Santosh Lumdas Saraf, MD7 shared papers
Recent publications by Dr. Ataga
See who Dr. Ataga researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Ataga works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kenneth I. Ataga has worked on 6 clinical trials
Dmand AI links Dr. Ataga to 6 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Anemia, Sickle Cell, Anemia, Hemolytic, Congenital and Albuminuria. Novartis Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Ataga that name 2 trials.
Clinical trials with Dr. Ataga by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Ataga's trials
- Anemia, Sickle Cell
- Anemia, Hemolytic, Congenital
- Albuminuria
- Kidney Failure, Chronic
- Sickle Cell Trait
Investigators on the most trials with Dr. Ataga
- Payal Chandarana Desai, MD3 shared trials
- Fuad El Rassi, MD2 shared trials
- Victor R. Gordeuk, MD2 shared trials
Recent clinical trials with Dr. Ataga
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (opens in a new tab)
Kidney Function in Sickle Cell Anemia (opens in a new tab)
A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kenneth I. Ataga received $182,186 in industry payments from 2017 to 2025
CMS Open Payments shows 130 general payments to Dr. Ataga from 17 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $47,437. It also lists 29 research payments totaling $10,971 from 2017 to 2025, naming 2 clinical trials.
General payments to Dr. Ataga by program year, 2017 to 2025
General payments to Dr. Ataga by kind, 2017 to 2025
- Consulting fees$126,28469%
- Travel and lodging$34,28919%
- Speaker and faculty fees$11,2836%
- Honoraria$7,7504%
- Food and beverage$2,5811%
Companies that paid Dr. Ataga the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Kenneth I. Ataga's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kenneth I. Ataga
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kenneth I. Ataga's NPI number?
Dr. Kenneth I. Ataga's NPI number is 1306886825. It was assigned on June 7, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Kenneth I. Ataga?
Dr. Kenneth I. Ataga is a hematologist and oncologist in Memphis, Tennessee. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Kenneth I. Ataga practice?
Dr. Ataga practices at 877 Jefferson Avenue, Memphis, TN 38103. Dr. Ataga's primary practice is Regional Medical Center in Memphis, Tennessee, part of Shelby County Government. Dmand AI also links Dr. Ataga to 2 medical groups and 1 group practice or clinic.
What is Dr. Kenneth I. Ataga's office phone number?
The practice phone on file for Dr. Ataga is (901) 545-7928.
What is Dr. Kenneth I. Ataga's medical license number?
Dr. Ataga holds Tennessee license 57803, one of the licenses on file in 2 states.
Which states has Dr. Kenneth I. Ataga been licensed in?
Dmand AI has state licenses on file for Dr. Ataga in Tennessee and North Carolina.
Which hospitals is Dr. Kenneth I. Ataga affiliated with?
Dr. Ataga practices at Regional Medical Center in Memphis, Tennessee. Dr. Ataga is also affiliated with Select Specialty Hospital - Memphis.
What medical group is Dr. Kenneth I. Ataga part of?
Dr. Ataga is linked to UT Regional One Physicians. Dmand AI links Dr. Ataga to 2 more medical groups.
Does Dr. Kenneth I. Ataga accept Medicare?
Yes. CMS data shows Dr. Ataga billed Medicare for 19 services in 2023, and Dr. Ataga accepts Medicare assignment.
What is Dr. Kenneth I. Ataga's MIPS score?
Dr. Ataga's MIPS final score for performance year 2024 is 81 out of 100, reported as part of a group.
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Kenneth I. Ataga see?
CMS counts 15 Medicare patients who saw Dr. Ataga in 2024, with an average age of 49.
What services does Dr. Kenneth I. Ataga bill to Medicare?
In 2023, Dr. Ataga's most billed Medicare services were office visit, established patient (99214).
What drugs does Dr. Kenneth I. Ataga prescribe most?
In 2024 Medicare Part D data, Dr. Ataga's most prescribed drugs by claims were Hydroxyurea, Endari and Adakveo.
Has Dr. Kenneth I. Ataga received payments from drug or device companies?
CMS Open Payments shows $182,186 in general payments to Dr. Ataga from 17 companies from 2017 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Kenneth I. Ataga been practicing?
Dr. Ataga graduated from medical school in 1990, 36 years ago.
Does Dr. Kenneth I. Ataga do research?
Dmand AI links 110 publications to Dr. Ataga, published from 2008 to 2025. Dr. Ataga has worked on 6 clinical trials.
Who does Dr. Kenneth I. Ataga publish with?
Dr. Ataga's most frequent co-authors are Payal Chandarana Desai, MD (15 shared papers), Nigel S. Key, MD (15 shared papers) and Santosh Lumdas Saraf, MD (7 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Tennessee by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card